1. Home
  2. PVLA vs INBK Comparison

PVLA vs INBK Comparison

Compare PVLA & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • INBK
  • Stock Information
  • Founded
  • PVLA 2015
  • INBK 1999
  • Country
  • PVLA United States
  • INBK United States
  • Employees
  • PVLA N/A
  • INBK N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • INBK Major Banks
  • Sector
  • PVLA Health Care
  • INBK Finance
  • Exchange
  • PVLA Nasdaq
  • INBK Nasdaq
  • Market Cap
  • PVLA 280.4M
  • INBK 228.1M
  • IPO Year
  • PVLA N/A
  • INBK N/A
  • Fundamental
  • Price
  • PVLA $22.77
  • INBK $23.23
  • Analyst Decision
  • PVLA Strong Buy
  • INBK Buy
  • Analyst Count
  • PVLA 7
  • INBK 4
  • Target Price
  • PVLA $44.43
  • INBK $34.50
  • AVG Volume (30 Days)
  • PVLA 82.1K
  • INBK 93.3K
  • Earning Date
  • PVLA 05-15-2025
  • INBK 04-23-2025
  • Dividend Yield
  • PVLA N/A
  • INBK 1.04%
  • EPS Growth
  • PVLA N/A
  • INBK 27.37
  • EPS
  • PVLA N/A
  • INBK 2.40
  • Revenue
  • PVLA N/A
  • INBK $114,609,000.00
  • Revenue This Year
  • PVLA N/A
  • INBK $3.03
  • Revenue Next Year
  • PVLA N/A
  • INBK $16.38
  • P/E Ratio
  • PVLA N/A
  • INBK $9.61
  • Revenue Growth
  • PVLA N/A
  • INBK 20.13
  • 52 Week Low
  • PVLA $6.20
  • INBK $19.54
  • 52 Week High
  • PVLA $29.27
  • INBK $43.26
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • INBK 49.58
  • Support Level
  • PVLA N/A
  • INBK $21.59
  • Resistance Level
  • PVLA N/A
  • INBK $22.56
  • Average True Range (ATR)
  • PVLA 0.00
  • INBK 1.33
  • MACD
  • PVLA 0.00
  • INBK 0.33
  • Stochastic Oscillator
  • PVLA 0.00
  • INBK 50.62

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking/treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

Share on Social Networks: